|


|
GENTAUR
+32
1658 9045
or
0032 (0)16 41 44
07
+32
1650 9045
info@gentaur.com
Av. de
l' Armée 68
B-1040
Brussels
BELGIUM

France
tel 01 43 25 01 50
fax01 43 25 01 60
9, rue Lagrange
75005 Paris

Italia
tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano

Deutschland
tel +32
1658 9045
fax +32
1650 9045

Polska
Tel 00 48 51 760 77
08
Fax 00 32 16 50 90 45
Ulica Ogarna 15/19 B
m2
80-826 Gdansk

日本
tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047


Österreich
+43720880899
Canada Montreal
+15149077481
Česká republika
Praha
+420246019719
Danmark
+4569918806
Finland Helsset
+358942419041
Ελλάς Αθήνα
+302111768494
Magyarország
Budapest
+3619980547
Ireland Dublin
+35316526556
Luxembourg
+35220880274
Nederland
+31208080893
Norge Oslo
+4721031366
Polska Warszawa
+48223988221
Sverige Stockholm
+46852503438
Schweiz Züri
+41435006251
US New York
+17185132983
Other Countries
0032 (0)16 41 44 07
|

|
|
| |
|
Fractalkine |
|
Cat. No. |
CCM13 |
|
Product Overview |
Recombinant Human
Fractalkine/CX3CL1
produced in
E. coli
is a
single, non-glycosylated polypeptide chain containing 76
amino acids
and having a molecular mass of
8.5
kDa. |
|
Description |
Fractalkine, also named neurotactin, is a novel
chemokine recently identified through bioinformatics.
Fractalkine has a unique C-X3-C cysteine motif near the
amino-terminus and is the first member of a fourth
branch of the chemokine superfamily. Unlike other known
chemokines, fractalkine is a type 1 membrane protein
containing a chemokine domain tethered on a long mucin-like
stalk. Human fractalkine cDNA encodes a 397 amino acid (aa)
residue membrane protein with a 24 aa residue predicted
signal peptide, a 76 aa residue chemokine domain, a 241
aa residue stalk region containing 17 degenerate mucin-like
repeats, a 19 aa residue transmembrane segment and a 37
aa residue cytoplasmic domain. The extracellular domain
of human fractalkine can be released, possibly by
proteolysis at the dibasic cleavage site proximal to the
membrane, to generate soluble fractalkine. The soluble
chemokine domain of human fractalkine was reported to be
chemotactic for T cells and monocytes while the soluble
chemokine domain of mouse fractalkine was reported to
chemoattract neutrophils and T-lymphocytes but not
monocytes. |
|
Purity |
>97% by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2mm filtered concentrated
(1.0mg/ml) solution in 20mM PB, pH 7.4, 50mM NaCl.
|
|
Endotoxin |
Less than 1EU/mg of rHuFractalkine/CX3CL1 as determined
by LAL method. |
|
Reconstitutionon |
We recommend that this vial be briefly centrifuged prior
to opening to bring the contents to the bottom.
Reconstitute in sterile distilled water or aqueous
buffer containing 0.1% BSA to a concentration of 0.1-1.0
mg/ml. Stock solutions should be apportioned into
working aliquots and stored at
<-20oC.
Further dilutions should be made in appropriate buffered
solutions. |
|
Storage |
This lyophilized preparation is stable for several weeks
at 2-8oC,
but should be kept at -20oC
for long term storage, preferably desiccated. Upon
reconstitution, the preparation is stable for up to one
week at 2-8oC.
For maximal stability, apportion the reconstituted
preparation into working aliquots and store at -20oC
to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CX3CL1 |
|
Synonyms |
ABCD-3; C3Xkine; CXC3; CXC3C; NTN; NTT; SCYD1;
fractalkine; neurotactin; A-152E5.2; C3Xkine; FKN; NTN;
NTT; Neurotactin; fractalkine; neurotactin; C-X3-C motif
chemokine 1; CX3C membrane-anchored chemokine;
Small-inducible cytokine D1; chemokine (C-X3-C motif)
ligand 1; small inducible cytokine subfamily D
(Cys-X3-Cys), member 1 (fractalkine, neurotactin); small
inducible cytokine subfamily D (Cys-X3-Cys), member-1;
X3CL1_HUMAN; Fractalkine [Precursor]. |
|
GeneID |
6376 |
|
mRNA Refseq |
NM_002996 |
|
Protein Refseq |
NP_002987 |
|
MIM |
601880 |
|
UniProt ID |
P78423 |
|
Chromosome Location |
16q13 |
|
Pathway |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine activity. |
| |
|

PDB rendering based on 1b2t.
Available structures:
1b2t,
1f2l
|
Download Datasheet:
|
|
|
|
Neutrophil-activating Protein
3 |
|
Cat. No. |
CCM14 |
|
Product Overview |
Recombinant Human GRO-alpha/CXCL1 produced in
E.
coli
is a
single, non-glycosylated polypeptide chain containing 73 amino
acids
and having a molecular mass of
7.8
kDa. |
|
Description |
The
three GRO cDNAs encode 107 amino acid precursor proteins from
which the N-terminal 34 amino acid residues are cleaved to
generate the mature GROs. There are no potential N-linked
glycosylation sites in the amino acid sequences. GRO expression
is inducible by serum or PDGF and/or by a variety of
inflammatory mediators, such as IL-1 and TNF, in monocytes,
fibroblasts, melanocytes and epithelial cells. In certain tumor
cell lines, GRO is expressed constitutively. Similar to other
alpha chemokines, the three GRO proteins are potent neutrophil
attractants and activators. In addition, these chemokines are
also active toward basophils. All three GROs can bind with high
affinity to the IL-8 receptor type B. |
|
Purity |
>97% by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2mm filtered concentrated (1mg/ml) solution
in 20mM PB, pH 7.4, 50mM NaCl. |
|
Endotoxin |
Less
than 1EU/mg of rHuGRO-alpha/CXCL1 as determined by LAL method. |
|
Reconstitutionon |
We
recommend that this vial be briefly centrifuged prior to opening
to bring the contents to the bottom. Reconstitute in sterile
distilled water or aqueous buffer containing 0.1% BSA to a
concentration of 0.1-1.0 mg/ml. Stock solutions should be
apportioned into working aliquots and stored at <-20oC.
Further dilutions should be made in appropriate buffered
solutions.
|
|
Storagee |
This
lyophilized preparation is stable for several weeks at 2-8oC,
but should be kept at -20oC for long term storage,
preferably desiccated. Upon reconstitution, the preparation is
stable for up to one week at 2-8oC. For maximal
stability, apportion the reconstituted preparation into working
aliquots and store at -20oC to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CXCL1 |
|
Synonyms |
FSP;
GRO; GRO1; GROA; GROa; MGSA; MGSA-a; NAP-3; SCYB1;
MGSA
alpha; C-X-C motif chemokine 1; GRO1 oncogene (melanoma growth
stimulating activity, alpha); GRO1 oncogene (melanoma
growth-stimulating activity); Melanoma growth stimulatory
activity; Neutrophil-activating protein 3; chemokine (C-X-C
motif) ligand 1; chemokine (C-X-C motif) ligand 1 (melanoma
growth stimulating activity, alpha); fibroblast secretory
protein; melanoma growth stimulatory activity alpha; GROA_HUMAN;
Growth-regulated alpha protein [Precursor]; GRO-alpha(1-73). |
|
GeneID |
2919 |
|
mRNA Refseq |
NM_001511 |
|
Protein Refseq |
NP_001502 |
|
MIM |
155730 |
|
UniProt ID |
P09341 |
|
Chromosome Location |
4q21 |
|
Pathway |
Cytokine-cytokine receptor interaction; Epithelial cell
signaling in Helicobacter pylori infection |
|
Function |
chemokine activity; enzyme activator activity; growth factor
activity |
| |
|

PDB rendering based on 1mgs.
Available structures:
1mgs,
1msg,
1msh
|
Download Datasheet:
 |
|
|
|
Macrophage
Inflammatory Protein 2-alpha |
|
Cat. No. |
CCM15 |
|
Product Overview |
Recombinant Human
GRO-beta/CXCL2
produced in E. coli is a single, non-glycosylated polypeptide
chain containing 73 amino acids and having a molecular mass of
7.9 kDa. |
|
Description |
The three GRO cDNAs encode 107 amino acid precursor proteins
from which the N-terminal 34 amino acid residues are cleaved to
generate the mature GROs. There are no potential N-linked
glycosylation sites in the amino acid sequences. GRO expression
is inducible by serum or PDGF and/or by a variety of
inflammatory mediators, such as IL-1 and TNF, in
monocytes,
fibroblasts, melanocytes and epithelial cells. In certain tumor
cell lines, GRO is expressed constitutively. Similar to other
alpha chemokines, the three GRO proteins are potent neutrophil
attractants and activators. In addition, these chemokines are
also active toward basophils. All three GROs can bind with high
affinity to the IL-8 receptor type B. |
|
Purity |
>97% by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2mm
filtered concentrated (1mg/ml) solution in 20mM PB, pH 7.4, 50mM
NaCl. |
|
Specific Activityty |
Fully biologically active when compared to standard. Determined
by its ability to chemoattract hCXCR2 transfected 293 cells
using a concentration range of 10.0-100.0 ng/ml. |
|
Endotoxin |
Less than 1EU/mg
of rHuGRO-beta/CXCL2 as determined by
LAL method. |
|
Reconstitutionon |
We
recommend that this vial be briefly centrifuged prior to opening
to bring the contents to the bottom. Reconstitute in sterile
distilled water or aqueous buffer containing 0.1% BSA to a
concentration of 0.1-1.0 mg/ml. Stock solutions should be
apportioned into working aliquots and stored at <-20oC.
Further dilutions should be made in appropriate buffered
solutions. |
|
Storagee |
This lyophilized preparation is stable for several weeks at 2-8oC,
but should be kept at -20oC
for long term storage, preferably desiccated. Upon
reconstitution, the preparation is stable for up to one week at
2-8oC.
For maximal stability, apportion the reconstituted preparation
into working aliquots and store at -20oC
to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CXCL2 chemokine (C-X-C motif) ligand 2 |
|
Synonyms |
GRO2; GROb; MIP2; MIP2A; SCYB2; MGSA-b; MIP-2a; CINC-2a;
MIP2-alpha; MIP-2a; Gro-beta; C-X-C motif chemokine 2; GRO2
oncogene; Growth-regulated protein beta; MGSA beta; chemokine
(C-X-C motif) ligand 2; melanoma growth stimulatory activity
beta; MIP2A_HUMAN; Macrophage inflammatory protein 2-alpha
[Precursor]; Gro-beta. |
|
GeneID |
2920 |
|
mRNA Refseq |
NM_002089 |
|
Protein Refseq |
NP_002080 |
|
MIM |
139110 |
|
UniProt ID |
P19875 |
|
Chromosome Location |
4q21 |
|
Pathway |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine activity |
| |
|
|
Download Datasheet:
 |
|
|
|
Macrophage Inflammatory
Protein-2-beta |
|
Cat. No. |
CCM16 |
|
Product Overview |
Recombinant Human
GRO-gamma/CXCL3
produced in E. coli is a single, non-glycosylated polypeptide
chain containing 73 amino acids and having a molecular mass of
7.9 kDa. |
|
Description |
The three GRO cDNAs encode 107 amino acid precursor proteins
from which the N-terminal 34 amino acid residues are cleaved to
generate the mature GROs. There are no potential N-linked
glycosylation sites in the amino acid sequences. GRO expression
is inducible by serum or PDGF and/or by a variety of
inflammatory mediators, such as IL-1 and TNF, in monocytes,
fibroblasts, melanocytes and epithelial cells. In certain tumor
cell lines, GRO is expressed constitutively. Similar to other
alpha chemokines, the three GRO proteins are potent neutrophil
attractants and activators. In addition, these chemokines are
also active toward basophils. All three GROs can bind with high
affinity to the IL-8 receptor type B. |
|
Purity |
>97% by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2mm
filtered concentrated (1mg/ml) solution in 20mM PB, pH 7.4, 50mM
NaCl. |
|
Specific Activityty |
Fully biologically active when compared to standard. Determined
by its ability to chemoattract hCXCR2 transfected 293 cells
using a concentration range of 10.0-100.0 ng/ml. |
|
Endotoxin |
Less than 1EU/mg
of rHuGRO-gamma/CXCL3 as determined by
LAL method. |
|
Reconstitutionon |
We
recommend that this vial be briefly centrifuged prior to opening
to bring the contents to the bottom. Reconstitute in sterile
distilled water or aqueous buffer containing 0.1% BSA to a
concentration of 0.1-1.0 mg/ml. Stock solutions should be
apportioned into working aliquots and stored at <-20oC.
Further dilutions should be made in appropriate buffered
solutions. |
|
Storagee |
This lyophilized preparation is stable for several weeks at 2-8oC,
but should be kept at -20oC for long term storage,
preferably desiccated. Upon reconstitution, the preparation is
stable for up to one week at 2-8oC. For maximal
stability, apportion the reconstituted preparation into working
aliquots and store at -20oC to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CXCL3 chemokine (C-X-C motif) ligand 3 |
|
Synonyms |
GRO3; GROg; MIP2B; SCYB3; MIP-2b; CINC-2b; GRO-gamma;
GRO-gamma(1-73); MIP2-beta; SCYB3; C-X-C motif chemokine 3; GRO3
oncogene; Growth-regulated protein gamma; MGSA gamma; chemokine
(C-X-C motif) ligand 3; melanoma growth stimulatory activity
gamma; Macrophage inflammatory protein 2-beta [Precursor];
MIP2B_HUMAN. |
|
GeneID |
2921 |
|
mRNA Refseq |
NM_002090 |
|
Protein Refseq |
NP_002081 |
|
MIM |
139111 |
|
UniProt ID |
P19876 |
|
Chromosome Location |
4q21 |
|
Pathway |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine activity |
| |
|
|
Download Datasheet:
 |
|
|
|
Chemokine (C-X-C motif)
Ligand 9 |
|
Cat. No. |
CCM17 |
|
Product Overview |
Recombinant Human MIG/CXCL9 produced in E. coli is a single,
non-glycosylated polypeptide chain containing 103 amino acids
and having a molecular mass of 11.7 kDa. |
|
Description |
CXCL9, a member of the α subfamily of chemokines that lack the
ELR domain, was initially identified as a lymphokine-activated
gene in mouse macrophages. The CXCL9 gene is induced in
macrophages and in primary glial cells of the central nervous
system specifically in response to IFN-γ. CXCL9 has been shown
to be a chemoattractant for activated T-lymphocytes and TIL but
not for neutrophils or monocytes. The human CXCL9 cDNA encodes a
125 amino acid residue precursor protein with a 22 amino acid
residue signal peptide that is cleaved to yield a 103 amino acid
residue mature protein. CXCL9 has an extended carboxy-terminus
containing greater than 50% basic amino acid residues and is
larger than most other chemokines. A chemokine receptor (CXCR3)
specific for CXCL9 and IP-10 has recently been cloned and shown
to be highly expressed in IL-2-activated T-lymphocytes. |
|
Purity |
>97% by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2mm
filtered concentrated (1.0mg/ml) solution in 20mM PB, pH 7.4,
50mM NaCl. |
|
Specific Activityty |
Fully biologically active when compared to standard. Determined
by its ability to chemoattract
human peripheral blood
T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml. |
|
Endotoxin |
Less than 1EU/mg
of rHuMIG/CXCL9 as determined by LAL method. |
|
Reconstitutionon |
We
recommend that this vial be briefly centrifuged prior to opening
to bring the contents to the bottom. Reconstitute in sterile
distilled water or aqueous buffer containing 0.1% BSA to a
concentration of 0.1-1.0 mg/ml. Stock solutions should be
apportioned into working aliquots and stored at <-20oC.
Further dilutions should be made in appropriate buffered
solutions. |
|
Storagee |
This lyophilized preparation is stable for several weeks at 2-8oC,
but should be kept at -20oC for long term storage,
preferably desiccated. Upon reconstitution, the preparation is
stable for up to one week at 2-8oC. For maximal
stability, apportion the reconstituted preparation into working
aliquots and store at -20oC to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CXCL9 chemokine (C-X-C motif) ligand 9 |
|
Synonyms |
CMK; MIG; Humig; SCYB9; crg-10; Gamma-interferon-induced
monokine; Small-inducible cytokine B9; chemokine (C-X-C motif)
ligand 9; monokine induced by gamma interferon; small inducible
cytokine B9; CXCL9_HUMAN; C-X-C motif chemokine 9 [Precursor];
Gamma-interferon-induced monokine. |
|
GeneID |
4283 |
|
mRNA Refseq |
NM_002416 |
|
Protein Refseq |
NP_002407 |
|
MIM |
601704 |
|
UniProt ID |
Q07325 |
|
Chromosome Location |
4q21 |
|
Pathway |
Cytokine-cytokine receptor interaction;Toll-like receptor
signaling pathway |
|
Function |
chemokine activity |
| |
|
|
Download Datasheet:
 |
|
|
|
Monocyte Chemotactic Protein 4 |
|
Cat. No. |
CCM18 |
|
Product Overview |
Recombinant human MCP-4/CCL13 is 8.6 kDa, a single, non-glycosylated
polypeptide chain containing 75 amino acids. |
|
Description |
CCL13 is a chemoattractant for monocytes and eosinophils, and
activates basophils. In addition, it has been reported to be
chemotactic for CD4+ and CD8+ T cells, with an activity almost
equivalent to that of MCP-3. The bioactivities of CCL13 is most
likely mediated by the CC chemokine receptors CCR-2 and CCR-3,
both of which have been shown to bind CCL13. |
|
Purity |
>96%
by SDS-PAGE and HPLC analyses. |
|
Formulation |
Lyophilized from a 0.2μm
filtered concentrated (1.0mg/ml) solution in 20mM PB, pH 7.4,
130mM NaCl. |
|
Specific Activityty |
Fully biologically active when compared to standard. Determined
by its ability to chemoattract human monocytes using a
concentration range of 10.0-100.0 ng/ml. |
|
Endotoxin |
Less than 1EU/μg
of rHuMCP-4/CCL13 as determined by LAL method. |
|
Reconstitutionon |
It is recommended to reconstitute the lyophilized rHuMCP-4/CCL13
in sterile distilled water or aqueous buffer containing 0.1% BSA
to a concentration of 0.1-1.0 mg/ml. Stock solutions should be
apportioned into working aliquots and stored at ≤-20oC.
Further dilutions should be made in appropriate buffered
solutions. |
|
Storagee |
This lyophilized preparation is stable for several weeks at 2-8oC,
but should be kept at -20oC for long term storage,
preferably desiccated. Upon reconstitution, the preparation is
stable for up to one week at 2-8oC. For maximal
stability, apportion the reconstituted preparation into working
aliquots and store at -20oC to -70oC.
Avoid repeated freeze/thaw cycles. |
|
Gene Information |
|
Gene Name |
CCL13 |
|
Synonyms |
CK-beta-10;CKb10; MCP-4; MCP4; MGC17134; NCC-1; NCC1; SCYA13;
SCYL1; Monocyte chemoattractant protein 4; Monocyte chemotactic
protein 4; Small-inducible cytokine A 13;chemokine (C-C motif)
ligand 13; new CC chemokine1; small inducible cytokine A 4;
small inducible cytokine subfamily A (Cys-Cys), member 13;
CCL13_HUMAN; C-C motif chemokine 13 [Precursor]. |
|
GeneID |
6357 |
|
mRNA Refseq |
NM_005408 |
|
Protein Refseq |
NP_005399 |
|
MIM |
601391 |
|
UniProt ID |
Q99616 |
|
Chromosome Location |
17q11.2 |
|
Pathway |
Cytokine-cytokine receptor interaction. |
|
Function |
Chemokine activity; signal transducer activity. |
| |
|
|
Download Datasheet:
 |
|
|
|
Human chemokine
(C-C motif) ligand 1 Fc-tagged |
|
Cat. No. |
CCM19 |
|
Description |
Chemokine (C-C
motif) ligand 1 (CCL1) is a small glycoprotein secreted by
activated T cells that belongs to a family inflammatory
cytokines known as chemokines. CCL1 attracts monocytes, NK
cells, and immature B cells and dendritic cells by interacting
with a cell surface chemokine receptor called CCR8. This
chemokine resides in a large cluster of CC chemokines on human
chromosome 17.A DNA sequence encoding the signal peptide from
human CCL1 was fused to the Fc region of human IgG1 via a
polypeptide linker. The chimeric protein was expressed in HEK293
cell line. |
|
Purity |
> 90%, as
determined by SDS-PAGE and visualized by silver stain. |
|
Endotoxin |
< 1.0 EU per 1
μg of the cytokine as determined by the LAL method. |
|
Storage |
Lyophilized
samples are stable for up twelve months at -20℃ to -70℃.Upon
reconstitution, this cytokine can be stored under sterile
conditions at 2℃ - 8℃ for one month or at -20℃ to -70℃ in a
manual defrost freezer for three months without detectable loss
of activity. Avoid repeated freeze-thaw cycles. |
|
Gene
Information
|
Gene Name |
CCL1 chemokine (C-C motif) ligand 1 |
|
Synonyms |
P500; SISe;
TCA3; I-309; SCYA1; small inducible cytokine A1; inflammatory
cytokine I-309; T lymphocyte-secreted protein I-309; small
inducible cytokine A1 (I-309, homologous to mouse Tca-3);
chemokine (C-C motif) ligand 1; |
|
GeneID |
6346 |
|
mRNA Refseq |
NM_002981 |
|
Protein Refseq |
NP_002972 |
|
MIM |
182281 |
|
Unitprot ID |
P22362 |
|
Chromosome
Location |
17q12 |
|
Pathway |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine
activity |
|
|
Download Datasheet:
 |
|
|
|
Human
chemokine (C-X-C motif) ligand 12 Fc-tagged |
|
Cat. No. |
CCM20 |
|
Description |
CXCL12 is
strongly chemotactic for lymphocytes. During embryogenesis it
directs the migration of hematopoietic cells from foetal liver
to bone marrow and the formation of large blood vessels. Mice
which were knocked-out for CXCL12 gene were lethal before the
birth or within just 1 hour of life.In adulthood CXCL12 plays an
important role in angiogenesis by recruiting endothelial
progenitor cells (EPC) from the bone morrow through a CXCR4
dependent mechanism. It is this function of CXCL12 that makes it
a very important factor in carcinogenesis and the
neovascularisation linked to tumour progression. A DNA sequence
encoding the signal peptide from human chemokine (C-X-C motif)
ligand 12 was fused to the Fc region of human IgG1 via a
polypeptide linker. The chimeric protein was expressed in HEK293
cell line. |
|
Purity |
> 90%, as
determined by SDS-PAGE and visualized by silver stain. |
|
Endotoxin |
< 1.0 EU per 1
μg of the cytokine as determined by the LAL method. |
|
Storage |
Lyophilized
samples are stable for up twelve months at -20℃ to -70℃.Upon
reconstitution, this cytokine can be stored under sterile
conditions at 2℃ - 8℃ for one month or at -20℃ to -70℃ in a
manual defrost freezer for three months without detectable loss
of activity. Avoid repeated freeze-thaw cycles. |
|
Gene
Information
|
Gene Name |
CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived
factor 1) |
|
Synonyms |
PBSF; SDF1;
SDF1A; SDF1B; TPAR1; hIRH; SDF-1; SCYB12; SDF-1a; SDF-1b;
TLSF-a; Pre-B cell growth-stimulating factor;TLSF-b; chemokine
(C-X-C motif) ligand 12 (stromal cell-derived factor 1); stromal
cell-derived factor 1; OTTHUMP00000019491; stromal cell-derived
factor 1a; stromal cell-derived factor 1 delta; stromal
cell-derived factor 1 gamma; C-X-C motif chemokine 12 |
|
GeneID |
6387 |
|
mRNA Refseq |
NM_000609
|
|
Protein Refseq |
NP_000600 |
|
MIM |
600835 |
|
Unitprot ID |
P48061 |
|
Chromosome
Location |
10q11.1
|
|
Pathway |
Axon guidance;
Cytokine-cytokine receptor interaction; Leukocyte
transendothelial migration. |
|
Function |
chemokine activity;
chemokine activity;
growth factor activity;signal
transducer activity |
|
|
|
|
Recombinant Murine stromal cell-derived factor 1 beta |
|
Cat. No. |
CCM21 |
|
Production
Description
|
SDF-1α and
SDF-1β, members of the chemokine α subfamily that lack the ELR
domain, were initially identified using the signal sequence trap
cloning strategy from a mouse bone-marrow stromal cell line.
These proteins were subsequently also cloned from a human
stromal cell line as cytokines that supported the proliferation
of a stromal cell-dependent pre-B-cell line. SDF-1α and SDF-1β
cDNAs encode precursor proteins of 89 and 93 amino acid
residues, respectively. Both SDF-1α and SDF-1β are encoded by a
single gene and arise by alternative splicing. The two proteins
are identical except for the four amino acid residues that are
present in the carboxy-terminus of SDF-1β and absent from
SDF-1α. |
|
Source |
Escherichia
coli. |
|
Molecular
Weight |
8.5 kDa, a
single, non-glycosylated polypeptide chain containing 72 amino
acids. |
|
Quantity |
2ug/10ug/1000μg |
|
Purity |
>97% by
SDS-PAGE and HPLC analyses. |
|
Biological
Activity |
Fully
biologically active when compared to standard. Determined by its
ability to chemoattract human monocytes using a concentration
range of 50.0-100.0 ng/ml. |
|
Physical
Appearance |
Sterile
Filtered White lyophilized (freeze-dried) powder. |
|
Formulation |
Lyophilized
from a 0.2μm filtered concentrated (1.0mg/ml) solution in 20mM
PB, pH 7.4, 150mM NaCl. |
|
Endotoxin |
Less than
1EU/μg of rMu SDF-1 beta /CXCL12 as determined by LAL method. |
|
AA Sequence |
KPVSLSYRCP
CRFFESHIAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE
YLEKALNKRL KM |
|
Reconstitution |
We recommend
that this vial be briefly centrifuged prior to opening to bring
the contents to the bottom. Reconstitute in sterile distilled
water or aqueous buffer containing 0.1% BSA to a concentration
of 0.1-1.0 mg/mL. Stock solutions should be apportioned into
working aliquots and stored at <-20°C. Further dilutions should
be made in appropriate buffered solutions. |
|
Storage |
This
lyophilized preparation is stable at 2-8°C, but should be kept
at -20°C for long term storage, preferably desiccated. Upon
reconstitution, the preparation is stable for up to one week at
2-8°C. For maximal stability, apportion the reconstituted
preparation into working aliquots and store at -20°C to -70°C.
Avoid repeated freeze/thaw cycles. |
|
Usage |
This material
is for research, laboratory or further evaluation purposes. NOT
FOR HUMAN USE. |
|
Gene
Information
|
Gene Name |
Cxcl12 chemokine (C-X-C motif) ligand 12 [ Mus musculus ] |
|
Synonyms |
CXCL12; PBSF;
SCYB12; SDF-1a; SDF-1b; SDF1; SDF1A; SDF1B; TLSF-a; TLSF-b;
TPAR1; chemokine (C-X-C motif) ligand 12; Sdf1; TLSF; SDF-1;
Sdf1a; Sdf1b; TPAR1; Scyb12; AI174028; PBSF/SDF-1; Cxcl12;
stromal cell derived factor 1; stromal cell derived factor
1;OTTMUSP00000026112; OTTMUSP00000026113; OTTMUSP00000026114;
pre-B-cell growth-stimulating factor; OTTHUMP00000019491; hIRH;
C-X-C motif chemokine 12; chemokine (C-X-C motif) ligand 12
(stromal cell-derived factor 1); stromal cell-derived factor 1;
stromal cell-derived factor 1 delta; stromal cell-derived factor
1 gamma; stromal cell-derived factor 1a. |
|
GeneID |
20315 |
|
mRNA Refseq |
NM_001012477 |
|
Protein Refseq |
NP_001012495 |
|
UniProt ID |
P40224 |
|
Chromosome
Location |
6 F1; 6 53.0 cM
|
|
Pathways |
Axon guidance;
Cytokine-cytokine receptor interaction; Leukocyte
transendothelial migration. |
|
Function |
Chemokine
activity; cytokine activity; growth factor activity. |
|

Chemokine (C-X-C motif) ligand 12 (stromal cell-derived
factor 1)
PDB rendering based on 1a15. Available structures:
1a15,
1qg7,
1sdf,
1vmc,
2j7z,
2nwg,
2sdf
|
Download Datasheet:
 |
|
|
|
BCA-1/BLC (CXCL13) |
|
Cat. No. |
CCM22 |
|
Product
Overview |
Recombinant
Human CXCL13 produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 87 amino acids and having a
molecular mass of 10.3 kDa. The BCA-1 is purified by proprietary
chromatographic techniques. |
|
Description |
BCA-1 is a CXC
chemokine that is highly expressed in thesecondary lymphoid
organs, such as follicles of the spleen, lymph nodes, and
Peyer's patches. CXCL13 promotes the migration of B lymphocytes
(compared to T cells and macrophages), by stimulating calcium
influx into, and chemotaxis of, cells expressing Burkitt's
lymphoma receptor 1 (BLR1). BCA1 therefore function in the
homing of B lymphocytes to follicles. Human BCA-1 shares a 64%
amino acid sequence similarity with the mouse protein and 23 -
34% amino acid sequence identity with other known CXC
chemokines. Recombinant or chemically synthesized BCA1 is a
potent chemoattractant for B lymphocytes but not T lymphocytes,
monocytes or neutrophils. BLR1, a G protein-coupled receptor
originally isolated from Burkitt’s lymphoma cells, has now been
shown to be the specific receptor for BCA1. |
|
Source |
Escherichia
Coli. |
|
Physical
Appearance |
Sterile
Filtered White lyophilized (freeze-dried) powder. |
|
Purity |
Greater than
97.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by
SDS-PAGE. |
|
Formulation |
The BCA-1
protein was lyophilized from a concentrated (0.5 mg/ml) solution
containing 20 mM PBS & 150 mM NaCl pH 7.4. |
|
Solubility |
It is
recommended to reconstitute the lyophilized CXCL13 in sterile 18
MΩ-cm H2O not less than 100 µg/ml, which can then be further
diluted to other aqueous solutions. |
|
Specific
Activity |
Determined by
its ability to chemoattract human B cells using a concentration
range of 1.0-10.0 ng/ml. |
|
Stability |
Lyophilized
BCA1 although stable at room temperature for 3 weeks, should be
stored desiccated below -18°C. Upon reconstitution BCA1 should
be stored at 4°C between 2-7 days and for future use below
-18°C. For long term storage it is recommended to add a carrier
protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
|
Gene
Information
|
Gene Name |
CXCL13 chemokine (C-X-C motif) ligand 13 [ Homo sapiens ] |
|
Synonyms
|
BLC; BCA1; BCA-1; BLR1L; ANGIE; ANGIE2;
SCYB13; CXCL13; B-cell chemoattractant; B-lymphocyte
chemoattractant; B lymphocyte chemoattractant; B-cell-attracting
chemokine 1; B cell-attracting chemokine 1; B-cell-homing
chemokine (ligand for Burkitt's lymphoma receptor-1); chemokine
(C-X-C motif) ligand 13; chemokine (C-X-C motif) ligand 13
(B-cell chemoattractant); CXC chemokine BLC; Small-inducible
cytokine B13; small inducible cytokine B subfamily (Cys-X-Cys
motif), member 13 (B-cell chemoattractant). |
|
GeneID |
10563 |
|
mRNA Refseq |
NM_006419 |
|
Protein Refseq |
NP_006410 |
|
MIM |
605149 |
|
UniProt ID |
O43927 |
|
Chromosome
Location |
4q21 |
|
Pathways |
Cytokine-cytokine receptor interaction; Leukocyte
transendothelial migration |
|
Function |
chemokine
activity |
|
|
Download Datasheet:
 |
|
|
|
HCC-1 (CCL14) |
|
Cat. No. |
CCM23 |
|
Product
Overview |
Recombinant
Human HCC-1 produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 72 amino acids and having a
molecular mass of 8411 Dalton. The HCC-1 is purified by
proprietary chromatographic techniques. |
|
Description |
Chemokine (C-C
motif) ligand 14 (CCL14) is a small cytokine belonging to the CC
chemokine family. It is also commonly known as HCC-1. It is
produced as a protein precursor that is procesed to generate a
mature active protein containing 74 amino acids that and is 46%
identical in amino acid composition to CCL3 and CCL4. This
chemokine is expressed in various tissues including spleen, bone
marrow, liver, muscle, and gut. CCL13 activates monocytes, but
does not induce their chemotaxis. Human CCL13 is located on
chromosome 17 within a cluster of other chemokines belonging to
the CC family. |
|
Source |
Escherichia
Coli. |
|
Physical
Appearance |
Sterile
Filtered White lyophilized (freeze-dried) powder. |
|
Purity |
Greater than
97.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by
SDS-PAGE. |
|
Formulation |
The CCL14
protein was lyophilized with 20 mM PBS pH 7.4 and 150 mM NaCl. |
|
Solubility |
It is
recommended to reconstitute the lyophilized HCC-1 in sterile 18
MΩ-cm H2O not less than 100 µg/ml, which can then be
further diluted to other aqueous solutions. |
|
Specific
Activity |
The Biological
activity is calculated by its ability to chemoattract Human
monocytes at 5-20 ng/ml. |
|
Stability |
Lyophilized HCC1 although stable at room
temperature for 3 weeks, should be stored desiccated below
-18°C. Upon reconstitution CCL14 should be stored at 4°C between
2-7 days and for future use below -18°C. For long term storage
it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles. |
|
Gene
Information
|
Gene Name |
CCL14 chemokine (C-C motif) ligand 14 [ Homo sapiens ] |
|
Synonyms
|
SCYA14; SY14;
SCYL2; HCC-1; HCC-3; NCC-2; NCC2; CKb1; MCIF; CC-1; CC-3;
CCL14; FLJ16015; HCC-1(1-74); HCC-1/HCC-3; chemokine (C-C
motif) ligand 14; chemokine CC-1; chemokine CC-3; Chemokine
CC-1/CC-3; OTTHUMP00000176860; Small-inducible cytokine A14;
small inducible cytokine subfamily A (Cys-Cys), member 14 |
|
GeneID |
6358 |
|
mRNA Refseq |
NM_004166 |
|
Protein Refseq |
NP_004157 |
|
MIM |
601392 |
|
UniProt ID |
Q16627 |
|
Chromosome
Location |
17q11.2 |
|
Pathways |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine
activity; protein binding; signal transducer activity |
|
|
Download Datasheet:
 |
|
|
|
Thymus
Activation-Regulated Chemokine |
|
Cat. No. |
CCM24 |
|
Product
Overview |
Recombinant
Human CCL17 produced in E.Coli is a single, non-glycosylated,
polypeptide chain containing 71 amino acids and having a
molecular mass of 8 kDa. The TARC is purified by proprietary
chromatographic techniques. |
|
Description |
Along with CC
chemokine family members, CCL-17 has approximately 24-29% amino
acid sequence identity with RANTES, MIP-1α, MIP-1β, MCP-1,
MCP-2, MCP-3 and I-309. TARC is expressed in thymus, and at a
lower level in the lung, colon, and small intestine. TARC is in
addition transiently expressed in stimulated peripheral blood
mononuclear cells. Recombinant TARC has been shown to be
chemotactic for T cell lines but not monocytes or neutrophils.
CCL-17 was recently identified to be a specific functional
ligand for CCR4, a receptor that is selectively expressed on T
cells. CCL17 is one of quite a few Cys-Cys (CC) cytokine genes
clustered on the q arm of chromosome 16. CCL17 binds to
chemokine receptors CCR4 and CCR8. This chemokine plays
important roles in T cell development in thymus as well as in
trafficking and activation of mature T cells. |
|
Source |
Escherichia
Coli. |
|
Physical
Appearance |
Sterile
Filtered White lyophilized (freeze-dried) powder. |
|
Purity |
Greater than
97.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by
SDS-PAGE. |
|
Formulation |
The protein was
lyophilized from a concentrated (0.5 mg/ml) solution containing
20 mM PBS & 150 mM NaCl pH 7.4. |
|
Solubility |
It is
recommended to reconstitute the lyophilized CCL17 in sterile 18
MΩ-cm H2O not less than 100 µg/ml, which can then be further
diluted to other aqueous solutions. |
|
Specific
Activity |
Determined by
its ability to chemoattract human T-Lymphocytes using a
concentration range of 1.0-10.0 ng/ml. |
|
Stability |
Lyophilized
TARC although stable at room temperature for 3 weeks, should be
stored desiccated below -18°C. Upon reconstitution TARC should
be stored at 4°C between 2-7 days and for future use below
-18°C. For long term storage it is recommended to add a carrier
protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
|
Gene
Information
|
Gene Name |
CCL17 chemokine (C-C motif) ligand 17 [ Homo sapiens ] |
|
Synonyms
|
chemokine (C-C
motif) ligand 17; TARC; ABCD-2; SCYA17; A-152E5.3; MGC138271;
MGC138273; CCL17; small inducible cytokine A17; T cell-directed
CC chemokine; thymus and activation-regulated chemokine; small
inducible cytokine subfamily A (Cys-Cys), member 17; CC
chemokine TARC; OTTHUMP00000164673 |
|
GeneID |
6361 |
|
mRNA Refseq |
NM_002987 |
|
Protein Refseq |
NP_002978 |
|
MIM |
601520 |
|
UniProt ID |
Q92583 |
|
Chromosome
Location |
16q13 |
|
Pathways |
Cytokine-cytokine receptor interaction |
|
Function |
chemokine
activity |
|

PDB
rendering based on 1nr2.
|
Download Datasheet:
 |
|
|
|